ISSN 1612-3352

Editors in Chief

Prof. Dr. Claus F. Claussen, Neurootological Research Institute of the Research Society for Smell, Taste, Hearing and Equilibrium Disorders at Bad Kissingen (4-G-F). Bad Kissingen, Germany.
Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.

Production Managers

Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.


Associated Editors


The editors welcome authors to submit articles for publications in the ASN.

Read the Information for Authors.


Kurhausstraße 12
D-97688 Bad Kissingen
Germany
Telefon +49-971-6 4832
Fax +49- 971- 6 8637
Email asn@neurootology.org

 

Publications tagged as

Betahistine

FIXED COMBINATION OF CINNARIZINE AND DIMENHYDRINATE VERSUS BETAHISTINE DIMESYLATE IN MÉNIÈRE’s DISEASE

ABSTRACT Background: Ménière’s disease (MD) is characterized by recurrent, sudden episodes of disabling vertigo. A previous randomized, controlled study demonstrated a high efficacy of a fixed combination of cinnarizine 20mg and dimenhydrinate 40mg (Arlevert®, tid.) in MD, with no statistically significant difference to betahistine (dimesylate salt, 12mg, tid). Objective: This post hoc analysis was performed [...]


Betahistine in vertebro-basilar insufficiency

The aim of the study was to observe the usefulness of Betaserc in therapy of vestibular disorders in the patients with vertebro-basilar insufficiency.


Investigation of betaserc in patients with auditory and vestibular disturbances

The AIM of this investigation is to evaluate the effect of Betaserc – 16 and 8 mg on the patients (workers in the system of transport), with vascular auditory and vestibular disturbances.


The effect of betahistine (betaserc) on vestibular function in vertebro-basilar insufficiency

The aim of the study was to observe the usefulness of Betaserc in therapy of vestibular disorders in the patients with vertebro-basilar insufficiency. 80 patients (43 female, 37 male) were tested on the base of videonystagmography, stabilometry and brain stem auditory evoked potentials. Betaserc was ordered in two separate doses: 3x 8mg and 3x 16 [...]


A choice of disease for studying vestibular compensation in man : the betahistine example

The author proposes, as disease for the study of drugs activity on vestibular compensation mechanisms in man, a peripheral labyrinthine disease without spontaneous nystagmus of type II or III. He evaluates the state of compensation by the evolution of static posturography parameters and by the score of Norre’s VHT (vestibular habituation training) during an observation [...]


Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of ménière’s disease: a rando

In a randomized, double-blind clinical study, we evaluated the efficacy and tolerability of the fixed combination of cinnarizine, 20 mg, and dimenhydrinate, 40 mg (Arlevert [ARL]) in comparison to betahistine dimesylate (12 mg) in 82 patients suffering from Ménière’s disease for at least 3 months and showing the characteristic triad of symptoms (paroxysmal vertigo attacks, [...]


Login

Registration

If you are not already registered, please register here for free.

If you are registered but have forgotten your password (or you never had one), click here to recover your password.

Proceedings of

Authors

Archives

2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |

(bi)gital»